N-propanoylmannosamine interferes with O-GlcNAc modification of the tyrosine 3-monooxygenase and stimulates dopamine secretion

Journal of Neuroscience Research

Volumn 86, Issue 3, 2008, Pages 647-652

  Bork, Kaya ^a   Kannicht, Christoph ^b   Nöhring, Sabine ^a   Reutter, Werner ^a   Weidemann, Wenke ^c   Hart, Gerald W ^d   Horstkorte, Rüdiger ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b PCR + D Molecular Biochemistry   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; Glycosylation; PC12 cells

Indexed keywords

DOPAMINE DERIVATIVE; MOLECULAR LAYER; N ACETYLGLUCOSAMINE; N PROPANOYLMANNOSAMINE; SERINE; SIALIC ACID; THREONINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; DOPAMINE RELEASE; HUMAN; NERVE FIBER GROWTH; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ACETYLGLUCOSAMINE; ANIMALS; DOPAMINE; DOWN-REGULATION; ENZYME ACTIVATION; GLYCOPROTEINS; HEXOSAMINES; PC12 CELLS; PHOSPHORYLATION; RATS; TYROSINE 3-MONOOXYGENASE;

EID: 38849174573     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21526     Document Type: Article

References (27)

1. Apfel SC. 2001. Neurotrophic factor therapy - prospects and problems. Clin Chem Lab Med 39:351-355.
2. Baizer L, Weiner N. 1985. Nerve growth factor treatment enhances nicotine-stimulated dopamine release and increases in cyclic adenosine 3′:5′-monophosphate levels in PC12 cell cultures. J Neurosci 5:1176-1179.
3. Bork K, Reutter W, Gerardy-Schahn R, Horstkorte R. 2005. The intracellular concentration of sialic acid regulates the polysialylation of the neural cell adhesion molecule. FEBS Lett 579:5079-5083.
4. Büttner B, Kannicht C, Schmidt C, Löster K, Reutter W, Lee H.-Y, Nöhring S, Horstkorte R. 2002. Biochemical engineering of cell surface sialic acids stimulates axonal growth. J Neurosci 22:8869-8875.
5. Chitnis T, Imitola J, Khoury SJ. 2005. Therapeutic strategies to prevent neurodegeneration and promote regeneration in multiple sclerosis. Curr Drug Targets Immune Endocr Metabol Disord 5:11-26.
6. Comer FI, Vosseller K, Wells L, Accavitti MA, Hart GW. 2001. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal Biochem 293:169-177.
7. Dunkley PR, Bobrovskaya L, Graham ME, von Nagy-Felsobuki EI, Dick PW. 2004. Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 91:1025-1043.
8. Fassbender K, Masters C, Beyreuther K. 2001. Alzheimer's disease: molecular concepts and therapeutic targets. Naturwissenschaften 88:261-267.
9. Gagiannis D, Gossrau R, Reutter W, Zimmermann-Kordmann M, Horstkorte R. 2007. Engineering the sialic acid in organs of mice using N- propanoylmannosamine. Biochem Biophys Acta 1770:297-306.
10. Greene LA, Tischler AS. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73:2424-2428.
11. Haavik J, Toska K. 1998. Tyrosine hydroxylase and Parkinson's disease. Mol Neurobiol 16:285-309.
12. 2+ rise and dopamine secretion in PC12 cells. J Neurochem 66:124-130.
13. Huang EJ, Reuchardt LF. 2003. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609-642.
14. Keppler OT, Stehling P, Herrmann M, Kayser H, Grunow D, Reutter W, Pawlita M. 1995. Biosynthetic modulation of sialic acid-dependent virus-receptor interactions of two primate polyoma viruses. J Biol Chem 270:1308-1314.
15. Keppler O, Horstkorte R, Pawlita M, Schmidt C, Reutter W. 2001. Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology 11:11R-18R.
16. Lefebvre T, Cieniewski C, Lemoine J, Guerardel Y, Leroy Y, Zanetta JP, Michalski JC. 2001. Identification of N-acetyl-D-glucosamine-specific lectins from rat liver cytosolic and nuclear compartments as heat-shock proteins. Biochem J 360:179-188.
17. NTR signaling in survival and cell death. Do intracellular mediators provide an explanation? J Neurosci Res 68:373-384.
18. Pillon B, Czernecki V, Dubois B. 2003. Dopamine and cognitive function. Curr Opin Neurol Suppl 2:S17-S22.
19. Samii A, Nutt JG, Ransom BR. 2004. Parkinson's disease. Lancet 363:1783-1793.
20. Schmidt C, Stehling P, Schnitzer J, Reutter W, Horstkorte R. 1998. Biochemical engineering of neural cell surfaces by the synthetic N-propanoyl-substituted neuraminic acid precursor. J Biol Chem 273:19146-19152.
21. Schmidt C, Ohlemeyer C, Kettenmann H, Reutter W, Horstkorte R. 2000. Incorporation of N-propanoylneuraminic acid leads to calcium oscillations upon the application of GABA. FEBS Lett 478:276-280.
22. Schulz KH, Gold SM, Witte J, Bartsch K, Lang UE, Hellweg R, Reer R, Braumann KM, Heesen C. 2004. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. J Neurol Sci 225:11-18.
23. Wells L, Hart GW. 2003. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar. FEBS Lett 546:154-158.
24. Whelan SA, Hart GW. 2003. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation. Circ Res 93:1047-1058.
25. Wise RA. 2004. Dopamine, learning and motivation. Nat Rev Neurosci 5:483-494.
26. Youdim MB, Buccafusco JJ. 2005. Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends Pharmacol Sci 26:27-35.
27. Zachara NE, Hart GW. 2004. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 1673:13-28.